Blood diagnostics company that uses machine vision and AI to transform health systems and outcomes through fast and accurate blood testing.
Sight has raised €60M across 1 funding round from 1 investor, most recently a Series D+ round in Aug 2020. Based in Tel Aviv, Israel; founded 2011; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-09 | Series D+ |
| €60M |
| Koch Disruptive Technologies |
| View deal → |
